David Blaine Ridley
Names
| first: |
David |
| middle: |
Blaine |
| last: |
Ridley |
Identifer
Contact
Affiliations
-
Duke University
/ Department of Economics (weight: 20%)
-
Duke University
/ Fuqua School of Business (weight: 80%)
Research profile
author of:
- The Role of Government Reimbursement in Drug Shortages (RePEc:aea:aejpol:v:9:y:2017:i:2:p:348-82)
by Ali Yurukoglu & Eli Liebman & David B. Ridley - Herding versus Hotelling: Market Entry with Costly Information (RePEc:bla:jemstr:v:17:y:2008:i:3:p:607-631)
by David B. Ridley - Innovation Incentives under Transferable Fast-Track Regulatory Review (RePEc:bla:jindec:v:61:y:2013:i:3:p:789-816)
by Joshua S. Gans & David B. Ridley - Herding versus Hotelling: Market Entry with Costly Information (RePEc:cla:levarc:814577000000000174)
by David B. Ridley - Strategic Interaction Among Governments in the Provision of a Global Public Good (RePEc:cpr:ceprdp:12419)
by Kyle, Margaret & Ridley, David & Zhang, Su - Distance decreases with differentiation: Strategic agglomeration by retailers (RePEc:eee:indorg:v:27:y:2009:i:3:p:463-473)
by Picone, Gabriel A. & Ridley, David B. & Zandbergen, Paul A. - Pharmaceutical followers (RePEc:eee:indorg:v:31:y:2013:i:5:p:538-553)
by Arcidiacono, Peter & Ellickson, Paul B. & Landry, Peter & Ridley, David B. - Regulation of price increases (RePEc:eee:indorg:v:50:y:2017:i:c:p:186-213)
by Ridley, David B. & Zhang, Su - Consequences of a shortage and rationing: Evidence from a pediatric vaccine (RePEc:eee:jhecon:v:92:y:2023:i:c:s0167629623000966)
by Liebman, Eli & Lawler, Emily C. & Dunn, Abe & Ridley, David B. - Strategic interaction among governments in the provision of a global public good (RePEc:eee:pubeco:v:156:y:2017:i:c:p:185-199)
by Kyle, Margaret K. & Ridley, David B. & Zhang, Su - Strategic interaction among governments in the provision of a global public good (RePEc:hal:journl:hal-01952672)
by Margaret Kyle & David Ridley & Su Zhang - Strategic interaction among governments in the provision of a global public good (RePEc:hal:journl:hal-01952712)
by Margaret Kyle & David Ridley & Su Zhang - The Role of Government Reimbursement in Drug Shortages (RePEc:nbr:nberwo:17987)
by Ali Yurukoglu & Eli Liebman & David B. Ridley - Pharmaceutical Followers (RePEc:nbr:nberwo:19522)
by Peter Arcidiacono & Paul B. Ellickson & Peter Landry & David B. Ridley - Consequences of a Shortage and Rationing: Evidence from a Pediatric Vaccine (RePEc:nbr:nberwo:31479)
by Eli B. Liebman & Emily C. Lawler & Abe Dunn & David B. Ridley - Impact of Medicaid Preferred Drug Lists on Therapeutic Adherence (RePEc:spr:pharme:v:24:y:2006:i:3:p:65-78)
by David Ridley & Kirsten Axelsen - Does Medicare Reimbursement Drive Up Drug Launch Prices? (RePEc:tpr:restat:v:102:y:2020:i:5:p:980-993)
by David B. Ridley & Chung-Ying Lee - Payments, Promotion, And The Purple Pill (RePEc:wly:hlthec:v:24:y:2015:i:1:p:86-103)
by David B. Ridley - Entry and competition in generic biologics (RePEc:wly:mgtdec:v:28:y:2007:i:4-5:p:439-451)
by Henry G. Grabowski & David B. Ridley & Kevin A. Schulman